Form 8-K - Current report:
SEC Accession No. 0001493152-24-038547
Filing Date
2024-09-27
Accepted
2024-09-27 16:31:12
Documents
15
Period of Report
2024-09-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48357
2 ex10-01.htm EX-10.01 75892
  Complete submission text file 0001493152-24-038547.txt   319466

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pali-20240927.xsd EX-101.SCH 3024
4 XBRL LABEL FILE pali-20240927_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pali-20240927_pre.xml EX-101.PRE 24171
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3731
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 241335367
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)